TrialBMC medicine2025

Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial.

Qingsheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.